Salts of N- [6-cis-2,6-dimethylmorpholin-4yl)pyridin e3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-b iphenyl]-3-carboxamide

Details for Australian Patent Application No. 2012201101 (hide)

Owner Novartis AG

Inventors Bajwa, Joginder Singh; De La Cruz, Marilyn; Dodd, Stephanie Kay; Waykole, Liladhae Murlidhar; Wu, Raeann

Agent Davies Collison Cave

Pub. Number AU-A-2012201101

Parent 2009293444

Filing date 24 February 2012

Wipo publication date 15 March 2012

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5377 (2006.01)

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

15 March 2012 Application Open to Public Inspection

  Published as AU-A-2012201101

15 March 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201102-Agents and methods for early diagnosis and monitoring of Alzheimer's disease and other neurological disorders

2012201100-Beverage products and flavor systems having a non-sweetening amount of monatin